Acadia Pharmaceuticals
ACAD
ACAD
266 hedge funds and large institutions have $2.99B invested in Acadia Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 103 increasing their positions, 75 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 275 → 266 (-9)
41% less capital invested
Capital invested by funds: $5.04B → $2.99B (-$2.05B)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
266
Holding in Top 10
5
Calls
$39.4M
Puts
$35.9M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$13.5M | |
| 3 | +$12.2M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$11.6M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$10.9M |
Top Sellers
| 1 | -$25.8M | |
| 2 | -$25.3M | |
| 3 | -$23.5M | |
| 4 |
Morgan Stanley
New York
|
-$23.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21.8M |